Skip to content
Thursday, November 12, 2026
Forgelink UK provides high-quality metal fabrication, engin…

The Zimbabwean Government Declines ‘Unbalanced’ US Healthcare Assistance Package Over Information Fears

Medical funding image
The proposed US financial assistance was aimed at initiatives for HIV/Aids treatment and prevention, tuberculosis, and malarial diseases.

Zimbabwe has rejected a significant US healthcare agreement valued at 367 million US dollars (272 million pounds) over five years over Washington's insistence on sensitive biological samples.

The decision was revealed after a government memo from December was disclosed, which showed President Emmerson Mnangagwa deemed the deal was "unbalanced".

An official spokesperson later stated that the US was requesting health data for research and commercial purposes while was unwilling to guarantee the benefits from any future treatments.

"We must now begin the challenging and unfortunate task of ending our health aid in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.

Her embassy noted the US had donated more than $1.9bn in health funding to Zimbabwe during the past twenty years.

A medical body in Zimbabwe has appealed for more dialogue to secure a agreement agreeable to all parties so the country's vital HIV treatment initiative can be sustained.

Broader Background

This rejection follows a similar situation in Kenya, where a high court blocked a related deal with the US following concerns were filed about the security of citizens' medical information.

After returning to office last year, US President Donald Trump has drastically cut foreign aid and closed the US Agency for International Development (USAID).

The agency had administered assistance for the US government, but Trump argued its spending was "wasteful" and his government was seeking government-to-government agreements to boost openness and accountability.

Based on reports, Sixteen nations in Africa have to date signed similar health pacts, representing more than $18.3bn in new funding.

Specifics of the Declined Deal

The funds for Zimbabwe was intended to gone towards "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and preparing for epidemics".

"It is our view this partnership might have yielded significant advantages for the people of Zimbabwe, especially the 1.2 million men, women and children presently on HIV treatment via US-supported initiatives," Tremont said.

However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".

"The proposal required Zimbabwe to surrender its biological resources and data over an extended period, without any equivalent guarantee of benefiting from any scientific breakthroughs – such as new medicines or tests – that might be developed from that shared data," Mangwana explained.

"Effectively, our nation would provide the basic resources for medical research with no certainty that the end products would be accessible to our citizens if a new pandemic emerge."

National Interest and Global Health

Mangwana further said that the US's withdrawal from the global health body and its pursuit of bilateral deals were upending frameworks already set up via the global health agency.

Mangwana cited its Pathogen Access and Benefit Sharing system designed to manage potential pandemics.

"This framework is intended to ensure that when a country contributes its data, the resulting advantages – such as medicines and cures – are distributed fairly, not commercialised solely by those with the funds to create them."

Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," he added.

"We welcome further dialogue with our American counterparts on how subsequent co-operation might be arranged in a way that respects the independence and dignity of each country."

Health Experts Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) said it understood the government's concerns, but recommended that negotiations must proceed considering a large portion of the country's HIV programmes depended on external financing.

"Where specific concerns arise, including those relating to information security or agreement terms, these can frequently be addressed through technical clarification and mutually agreed protections," the group said.

This impasse underscores the ongoing debate between receiving vital foreign assistance and protecting a country's data in an increasingly data-driven world.

CR
About the author

Christopher Rich

Elara Vance is a metallurgical engineer with over 15 years of experience in industrial fabrication and project management, specializing in sustainable metal solutions.

Forgelink UK

Type to search articles.